3 | SEC Filings Hub

Filing metadata

Accession number: 0001209191-23-013482
Form type: Form 3
Filer: Enliven Therapeutics, Inc.
CIK: CIK 1672619
Filed: Feb 27, 2023
Reporting period: Feb 23, 2023
Description: Initial ownership

Documents

0001209191-23-013482-index.htm

Complete submission

0001209191-23-013482.txt

directory listing

Filed by

Enliven Therapeutics, Inc.